想要对抗慢性疾病?停止补贴制药公司。

Modern healthcare Pub Date : 2017-05-01

Merrill Goozner

{"title":"想要对抗慢性疾病?停止补贴制药公司。","authors":"Merrill Goozner","doi":"","DOIUrl":null,"url":null,"abstract":"Healthcare systems have made great strides in recent years in learning how to use their medical records and claims data to identify patients at high risk of contracting chronic diseases such as diabetes. Unfortunately, under fee-for-service medicine, doing something with that information is rarely a smart move financially.","PeriodicalId":74209,"journal":{"name":"Modern healthcare","volume":"47 20","pages":"26"},"PeriodicalIF":0.0000,"publicationDate":"2017-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Want to fight chronic disease? Stop subsidizing drug companies.\",\"authors\":\"Merrill Goozner\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Healthcare systems have made great strides in recent years in learning how to use their medical records and claims data to identify patients at high risk of contracting chronic diseases such as diabetes. Unfortunately, under fee-for-service medicine, doing something with that information is rarely a smart move financially.\",\"PeriodicalId\":74209,\"journal\":{\"name\":\"Modern healthcare\",\"volume\":\"47 20\",\"pages\":\"26\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Modern healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern healthcare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

近年来，医疗保健系统在学习如何使用医疗记录和索赔数据来识别患有糖尿病等慢性病的高风险患者方面取得了长足的进步。不幸的是，在按服务收费的医疗制度下，从财务上讲，利用这些信息做点什么并不是明智之举。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Want to fight chronic disease? Stop subsidizing drug companies.

Healthcare systems have made great strides in recent years in learning how to use their medical records and claims data to identify patients at high risk of contracting chronic diseases such as diabetes. Unfortunately, under fee-for-service medicine, doing something with that information is rarely a smart move financially.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助